Quantcast

Latest Autoimmunity Stories

2014-09-30 12:29:58

WASHINGTON, Sept. 30, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced four grants that will allow lupus investigators to continue critical lupus research. An additional grant has been awarded to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis. http://photos.prnewswire.com/prnvar/20121113/DC11393LOGO The Lupus Foundation of...

2014-09-26 08:25:39

Comedian Jo Koy will serve as Walk Ambassador for San Francisco's Walk to End Lupus Now on October 26th WASHINGTON, Sept. 26, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its annual Walk To End Lupus Now(TM )event in San Francisco on Sunday, October 26, 2014 at Golden Gate Park. Walk Ambassador, comedian Jo Koy, will join thousands of San Francisco residents to raise money for lupus research and education programs, increase awareness of the disease, and...

2014-09-22 23:07:11

According to new report from BCC Research, the global market for autoimmune disease diagnostics is expected to grow to nearly $13.1 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.6%. Wellesley, Mass. (PRWEB) September 22, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, AUTOIMMUNE DISEASE DIAGNOSTICS: GLOBAL MARKETS, the global market for autoimmune disease diagnostics is expected to grow to nearly $13.1 billion by 2019, with a...

2014-09-17 08:31:07

-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc. today announced that it has entered into an exclusive technology development partnership with Novotectid GmbH for the development of antibody-based imaging agents to image CD4+ positive immune T cells. "Our collaboration with Novotectid expands ImaginAb's capability to precisely diagnose and determine...

2014-09-15 12:27:50

Hundreds Step Up For New Lupus Treatments NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Over 200 patients, families, physicians and scientists came together under one roof Saturday to learn, interact and participate in the drive for better lupus treatments at New York City's first Lupus Trials Fair launched by the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation. Attendees interacted directly with researchers at eight of NYC's leading institutions -- sharing experiences,...

2014-09-09 12:28:50

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing WASHINGTON, Sept. 9, 2014 /PRNewswire-USNewswire/ -- Today, the Lupus Foundation of America, the only national force devoted to solving the mystery of lupus, and the Rheumatology Research Foundation, the largest private funding source of rheumatology research and training programs, convened on Capitol Hill to update our nation's leaders about the new Accelerating Medicines Partnership (AMP)...

macrophages engulf dead cells
2014-09-08 02:00:50

Salk Institute Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies. In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day. When these garbage disposals don’t do their job, dead cells and their waste products rapidly pile up, destroying healthy tissue and leading to autoimmune...

2014-09-08 08:31:19

SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, has exercised its option to acquire a novel antibody program from AnaptysBio. Upon payment of an option exercise fee to...

2014-09-04 12:26:34

DIEPENBEEK, Belgium, September 4, 2014 /PRNewswire/ -- Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that Bristol University research led by Apitope Founder and CSO, Prof David Wraith, on its treatment approach to autoimmune diseases, such as Multiple Sclerosis (MS), has been published...

2014-09-01 04:20:02

A*STAR scientists find new targets for modulating antibody response Singapore, Sept 1, 2014 - (ACN Newswire) - Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have uncovered the crucial role of two signalling molecules, DOK3 and SHP1, in the development and production of plasma cells. These discoveries, published in two prestigious journals PNAS and Nature Communications, advance the understanding of plasma cells and...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related